Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
BioSpace
Merck
vaccines
Gardasil
legal
HPV
side effects
Flag link:
Rain Oncology Plummets after Lead Candidate Disappoints in Phase 3
Rain Oncology Plummets after Lead Candidate Disappoints in Phase 3
Tip Ranks
Rain Oncology
liposarcoma
clinical trials
milademetan
Flag link:
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Astellas
Iveric Bio
Bayer
Amgen
M&A
Flag link:
Orthopedic markets to return to normal this year as post-pandemic boost fades: analysts
Orthopedic markets to return to normal this year as post-pandemic boost fades: analysts
Medtech Dive
Medtech
Orthopedics
pandemic
COVID-19
Flag link:
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
Yahoo/Reuters
JNJ
Amgen
patents
Stelara
biosimilars
legal
Flag link:
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Fierce Biotech
Bristol Myers Squibb
clinical trials
BMS-986278
idiopathic pulmonary fibrosis
Flag link:
Top three unmet needs to target in Parkinson’s disease
Top three unmet needs to target in Parkinson’s disease
Clinical Trials Arena
Parkinson's Disease
drug devlopment
Flag link:
2 small biotechs morph to work on oncology together
2 small biotechs morph to work on oncology together
Fierce Biotech
CohBar
Morphogenesis
TuHURA Biosciences
immuno-oncology
Flag link:
May 23 2023 - Wave's ALS-dementia drug crashes out after early-phase flop
Flag link:
Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target
Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target
Fierce Biotech
Wave Life Sciences
antisense
WVE-004
clinical trials
ALS
dementia
Flag link:
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
Globe Newswire
Larkspur Biosciences
immunotherapy
cancer
funding
Flag link:
Roche Terminates Second Phase II Schizophrenia Trial
Roche Terminates Second Phase II Schizophrenia Trial
BioSpace
Roche
schizophrenia
ralmitaront
clinical trials
Flag link:
Affimed reveals 25% of staff were laid off in April in wake of phase 2 lymphoma fail
Affimed reveals 25% of staff were laid off in April in wake of phase 2 lymphoma fail
Fierce Biotech
Affimed
layoffs
lymphoma
Flag link:
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Investors Business Daily
Pfizer
Novo Nordisk
weight loss
Ozempic
danuglipron
clinical trials
Flag link:
Achieve's anti-smoking drug beats placebo in 2nd phase 3, keeping biotech on course for FDA filing
Achieve's anti-smoking drug beats placebo in 2nd phase 3, keeping biotech on course for FDA filing
Fierce Biotech
Achieve Life Sciences
smoking cessation
cytisinicline
clinical trials
Flag link:
Immunovant Shares Touch 52-Week High After FDA Green Lights IMVT-1402 Study
Immunovant Shares Touch 52-Week High After FDA Green Lights IMVT-1402 Study
Marketwatch
Immunovant
immunology
IMVT-1402
autoimmune disease
FDA
Flag link:
LabGenius utilizing machine learning to ‘transform’ cancer treatment
LabGenius utilizing machine learning to ‘transform’ cancer treatment
Biopharma Reporter
LabGenius
machine learning
antibody discovery
artificial intelligence
cancer
Flag link:
Elizabeth Holmes' Impending Prison Date
Elizabeth Holmes' Impending Prison Date
Medical Devices and Diagnostics Industry
Elizabeth Holmes
legal
prison
Theranos
fraud
Flag link:
Moderna vets help launch new RNA venture with $300M in largest financing round of 2023 so far
Moderna vets help launch new RNA venture with $300M in largest financing round of 2023 so far
Fierce Biotech
ReNAgade Therapeutics
RNA
Moderna Therapeutics
funding
Flag link:
Novo Nordisk’s trial of oral semaglutide meets primary endpoint
Novo Nordisk’s trial of oral semaglutide meets primary endpoint
Clinical Trials Arena
Novo Nordisk
semaglutide
oral semaglutide
clinical trials
weight loss
Flag link:

Pages